Inspire Medical Systems Reports Q4 Preliminary Revenue, Names Matt Osberg as CFO

MT Newswires Live01-12

Inspire Medical Systems (INSP) reported Q4 preliminary revenue Monday in the range of $268.9 million to $269.1 million, up roughly 12% year over year.

Analysts polled by FactSet expect $262.2 million.

Full-year 2025 revenue is now projected to be in the range of $911.8 million to $912 million, compared with previous outlook of $900 million to $910 million, the company said.

Analysts surveyed by FactSet expect $905.2 million.

For 2026, the company said it continues to expect revenue to grow 10% to 11% to a range of $1.00 billion to $1.01 billion.

Analysts surveyed by FactSet expect $1.01 billion.

Additionally, the company said Matt Osberg has been appointed as chief financial officer, starting Jan. 19.

Osberg was most recently CFO at Apogee Enterprises (APOG), the company said.

Shares of Inspire Medical Systems were up 2% in recent premarket activity Monday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment